Š Renub Research
Page 1 of 16
Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market. This is the 2nd edition report on Osteoporosis by Renub Research. Report titled “Global Osteoporosis Market, Patients, Companies & Forecast” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 124 page report with 89 Figures and 8 Tables studies the Worldwide Osteoporosis market from 6 view points: 1) Osteoporosis Patients & Forecast 2) Hip fracture Patients & Forecast 3) Osteoporosis Market & Forecast 4) Country Wise Osteoporosis level of Awareness, Guidelines & Policy 5) Country Wise Reimbursement of Medication 6) Company Wise Osteoporosis Drugs Sales & Forecast All the 10 Countries studied in the report are as follows 1) India 2) China 3) Japan 4) Korea 5) Brazil 6) Russia 7) United Kingdom 8) France 9) Germany 10) United States
© Renub Research
Page 2 of 16
Worldwide Osteoporosis – Company Wise Drugs Sales Analysis (2010 – 2019)
1) Merck 2) Sanofi 3) Novartis 4) Eli Lilly 5) Amgen
Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephonic interviews with industry experts. Secondary sources information and data has been collected from various printable and non– printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
© Renub Research
Page 3 of 16
About Us Renub Research
is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long–term experience especially in international Business–to–Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio–Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra–competitive markets.
For more information on us or to view any of our sample work you can mail us at info@renub.com
© Renub Research
Page 4 of 16
Published By
Renub Research 1st Floor C – 86, Sector – 10 Noida – 201301 Phone: +91–120–421–9822, 254–5750 (India) +1–678–302–0700 (USA) Fax : +91–120–424–9780 Email: info@renub.com www.renub.com
© Global Osteoporosis Market, Patients, Companies & Forecast Renub Research, 2015 Edition 2.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers
© Renub Research
Page 5 of 16
Table of Contents 1.
Executive Summary
2.
Worldwide Osteoporosis Patients Population Analysis 2.1
Worldwide Osteoporosis Patients Population (2010 – 2019)
2.2
Worldwide Hip Fracture Patients Population (2010 – 2019)
3.
Worldwide Osteoporosis Market (2010 – 2019)
4.
Worldwide Osteoporosis Share Analysis
5.
6.
4.1
Worldwide Osteoporosis Patients Population Share (2010 – 2019)
4.2
Worldwide Hip Fracture Patients Population Share (2010 – 2019)
4.3
Worldwide Osteoporosis Market Share (2010 – 2019)
4.4
Worldwide Osteoporosis Drugs Company Market Share (2010 – 2019)
India 5.1
India Osteoporosis Patients Population (2010 – 2019)
5.2
India Hip Fracture Patients Population (2010 – 2019)
5.3
India Osteoporosis Market (2010 – 2019)
5.4
Level of Awareness
5.5
Fracture Registries
5.6
Government Policies
5.7
Guidelines
5.8
Reimbursement of Medication
China 6.1
China Osteoporosis Patients Population (2010 – 2019)
6.2
China Hip Fracture Patients Population (2010 – 2019)
6.3
China Osteoporosis Market (2010 – 2019)
6.4
Level of Awareness
6.5
Fracture Registries
6.6
Government Policies
© Renub Research
Page 6 of 16
6.7
Guidelines
6.8
Reimbursement of Medication
7.
Japan 7.1
Japan Osteoporosis Patients Population (2010 – 2019)
7.2
Japan Hip Fracture Patients Population (2010 – 2019)
7.3
Japan Osteoporosis Market (2010 – 2019)
7.4
Level of Awareness
7.5
Fracture Registries
7.6
Government Policies
7.7
Guidelines
7.8
Reimbursement of Medication
8.
Korea 8.1
Korea Osteoporosis Patients Population (2010 – 2019)
8.2
Korea Hip Fracture Patients Population (2010 – 2019)
8.3
Korea Osteoporosis Market (2010 – 2019)
8.4
Level of Awareness
8.5
Fracture Registries
8.6
Government Policies
8.7
Guidelines
8.8
Reimbursement of Medication
9.
Brazil 9.1
Brazil Osteoporosis Patients Population (2010 – 2019)
9.2
Brazil Hip Fracture Patients Population (2010 – 2019)
9.3
Brazil Osteoporosis Market (2010 – 2019)
9.4
Level of Awareness
9.5
Guidelines & Policy
9.6
Reimbursement Policy
10.
Russia
© Renub Research
Page 7 of 16
10.1
Russia Osteoporosis Patients Population (2010 – 2019)
10.2
Russia Hip Fracture Patients Population (2010 – 2019)
10.3
Russia Osteoporosis Market (2010 – 2019)
10.4
Level of Awareness
10.5
Government Policy
10.6
Guidelines
10.7
Reimbursement
11.
United Kingdom
11.1
United Kingdom Osteoporosis Patients Population (2010 – 2019)
11.2
United Kingdom Hip Fracture Patients Population (2010 – 2019)
11.3
United Kingdom Osteoporosis Market (2010 – 2019)
11.4
Guidelines
11.5
Reimbursement Policy
12.
France
12.1
France Osteoporosis Patients Population (2010 – 2019)
12.2
France Hip Fracture Patients Population (2010 – 2019)
12.3
France Osteoporosis Market (2010 – 2019)
12.4
Guidelines
12.5
Reimbursement Policy
13.
Germany
13.1
Germany Osteoporosis Patients Population (2010 – 2019)
13.2
Germany Hip Fracture Patients Population (2010 – 2019)
13.3
Germany Osteoporosis Market (2010 – 2019)
13.4
Guidelines
13.5
Reimbursement Policy
14.
United States
14.1
United States Osteoporosis Patients Population (2010 – 2019)
14.2
United States Hip Fracture Patients Population (2010 – 2019)
© Renub Research
Page 8 of 16
14.3
United States Osteoporosis Market (2010 – 2019)
14.4
Policy
14.5
Guidelines
14.6
Reimbursement Policy
15.
Growth Driver
15.1
Widespread Vitamin D Deficiency & Low Calcium Intake
15.2
Globally Increasing Ageing Population & Life Expectancy
16.
Challenges
16.1
Lack of Reimbursement / Other Restrictions for Reimbursement
16.2
Limited Access of Diagnostic Tools & Low Levels of Public and Health Professional Awareness
16.3
Lack of Government Osteoporosis Policy, Guidelines & National Health Priority in Asia Pacific
Countries 17.
Key Players Osteoporosis Drugs Sales & Forecast
17.1
Merck Osteoporosis Drugs Sales (2010 – 2019)
17.2
Sanofi Osteoporosis Drugs Sales (2010 – 2019)
17.3
Novartis Osteoporosis Drugs Sales (2010 – 2019)
17.4
Eli Lilly Osteoporosis Drugs Sales (2010 – 2019)
17.5
Amgen Osteoporosis Drugs Sales (2010 – 2019)
© Renub Research
Page 9 of 16
List of Figures Figure 2–1: Worldwide – Osteoporosis Patients Population (Thousand), 2010 – 2014 Figure 2–2: Worldwide – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 2–3: Worldwide – Distribution of Hip Fracture Risk in Men, 2012 Figure 2–4: Worldwide – Distribution of Hip Fracture Risk in Women, 2012 Figure 2–5: Worldwide – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 2–6: Worldwide – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 3–1: Worldwide – Osteoporosis Market (Million US$), 2010 – 2014 Figure 3–2: Worldwide – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 4–1: Worldwide – Osteoporosis Patients Population Share (Percent), 2010 – 2014 Figure 4–2: Worldwide – Forecast for Osteoporosis Patients Population Share (Percent), 2015 – 2019 Figure 4–3: Worldwide – Hip Fracture Patients Population Share (Percent), 2010 – 2014 Figure 4–4: Worldwide – Forecast for Hip Fracture Patients Population Share (Percent), 2015 – 2019 Figure 4–5: Worldwide – Osteoporosis Market Share (Percent), 2010 – 2014 Figure 4–6: Worldwide – Forecast for Osteoporosis Market Share (Percent), 2015 – 2019 Figure 4–7: Worldwide – Osteoporosis Drugs Company Market Share (Percent), 2010 – 2014 Figure 4–8: Worldwide – Forecast for Osteoporosis Drugs Company Market Share (Percent), 2015 – 2019 Figure 5–1: India – Osteoporosis Patients Population (Thousand), 2010 – 2014 Figure 5–2: India – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 5–3: India – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 5–4: India – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 5–5: India – Osteoporosis Market (Million US$), 2010 – 2014 Figure 5–6: India – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 6–1: China – Osteoporosis Patients Population (Thousand), 2010 – 2014 Figure 6–2: China – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 6–3: China – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 6–4: China – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 6–5: China – Osteoporosis Market (Million US$), 2010 – 2014 Figure 6–6: China – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 7–1: Japan – Osteoporosis Patients Population (Thousand), 2010 – 2014 Figure 7–2: Japan – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 7–3: Japan – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 7–4: Japan – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 7–5: Japan – Osteoporosis Market (Million US$), 2010 – 2014 Figure 7–6: Japan – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 8–1: Korea – Osteoporosis Patients Population (Thousand), 2010 – 2014
© Renub Research
Page 10 of 16
Figure 8–2: Korea – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 8–3: Korea – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 8–4: Korea – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 8–5: Korea – Osteoporosis Market (Million US$), 2010 – 2014 Figure 8–6: Korea – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 9–1: Brazil – Osteoporosis Patients Population (Thousand), 2010 – 2014 Figure 9–2: Brazil – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 9–3: Brazil – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 9–4: Brazil – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 9–5: Brazil – Osteoporosis Market (Million US$), 2010 – 2014 Figure 9–6: Brazil – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 10–1: Russia – Osteoporosis Patients Population (Thousand), 2010 – 2014 Figure 10–2: Russia – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 10–3: Russia – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 10–4: Russia – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 10–5: Russia – Osteoporosis Market (Million US$), 2010 – 2014 Figure 10–6: Russia – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 10–7: Russia – Level of Awareness (Percent), 2010 Figure 11–1: United Kingdom – Osteoporosis Patients Population (Thousand), 2010 – 2014 Figure 11–2: United Kingdom – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019. Figure 11–3: United Kingdom – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 11–4: United Kingdom – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 11–5: United Kingdom – Osteoporosis Market (Million US$), 2010 – 2014 Figure 11–6: United Kingdom – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 12–1: France – Osteoporosis Patients Population (Thousand), 2010 – 2014 Figure 12–2: France – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 12–3: France – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 12–4: France – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 12–5: France – Osteoporosis Market (Million US$), 2010 – 2014 Figure 12–6: France – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 13–1: Germany – Osteoporosis Patients Population (Thousand), 2010 – 2014 Figure 13–2: Germany – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 13–3: Germany – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 13–4: Germany – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 13–5: Germany – Osteoporosis Market (Million US$), 2010 – 2014 Figure 13–6: Germany – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 14–1: United States – Osteoporosis Patients Population (Thousand), 2010 – 2014
© Renub Research
Page 11 of 16
Figure 14–2: United States – Forecast for Osteoporosis Patients Population (Thousand), 2015 – 2019 Figure 14–3: United States – Hip Fracture Patients Population (Thousand), 2010 – 2014 Figure 14–4: United States – Forecast for Hip Fracture Patients Population (Thousand), 2015 – 2019 Figure 14–5: United States – Osteoporosis Market (Million US$), 2010 – 2014 Figure 14–6: United States – Forecast for Osteoporosis Market (Million US$), 2015 – 2019 Figure 15–1: Worldwide – Ageing Population & Forecast (Million), 2010 – 2050 Figure 15–2: Worldwide – Life Expectancy (Year), 1990, 2000 & 2012 Figure 17–1: Merck – Osteoporosis Drugs Sales (Million US$), 2010 – 2014 Figure 17–2: Merck – Forecast for Osteoporosis Drugs Sales (Million US$), 2015 – 2019 Figure 17–3: Sanofi – Osteoporosis Drugs Sales (Million US$), 2010 – 2014 Figure 17–4: Sanofi – Forecast for Osteoporosis Drugs Sales (Million US$), 2015 – 2019 Figure 17–5: Novartis – Osteoporosis Drugs Sales (Million US$), 2010 – 2014 Figure 17–6: Novartis – Forecast for Osteoporosis Drugs Sales (Million US$), 2015 – 2019 Figure 17–7: Eli Lilly – Osteoporosis Drugs Sales (Million US$), 2010 – 2014 Figure 17–8: Eli Lilly – Forecast for Osteoporosis Drugs Sales (Million US$), 2015 – 2019 Figure 17–9: Amgen – Osteoporosis Drugs Sales (Million US$), 2010 – 2014 Figure 17–10: Amgen – Forecast for Osteoporosis Drugs Sales (Million US$), 2015 – 2019
© Renub Research
Page 12 of 16
List of Tables Table 5–1: India – Osteoporosis Treatments & Respective Reimbursement Status, 2013 Table 6–1: China – Osteoporosis Treatments & Respective Reimbursement Status, 2013 Table 7–1: Japan – Osteoporosis Treatments & Respective Reimbursement, 2013 Table 8–1: Korea – Osteoporosis Treatments & Respective Reimbursement, 2013 Table 11–1: United Kingdom – Available Medical Interventions & Reimbursement Policies, 2013 Table 12–1: France – Available Medical Interventions & Reimbursement Policies, 2013 Table 13–1: Germany – Available Medical Interventions & Reimbursement Policies, 2013 Table 16–1: Asia Pacific – Status of Osteoporosis in NHP & Guidelines Availability, 2013
© Renub Research
Page 13 of 16
Order Form Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call
+91-120-421-9822 (India),
+1-678-302-0700
(USA)
or
info@renub.com
Format Report Title: Global Osteoporosis Market, Patients, Companies & Forecast
Single User (Email from Publisher)
Hard Copy (Mail Delivery)
CD – Rom (Mail Delivery)
Global Site License (Multiple User License)
US$ 1100
US$ 1200
US$ 1200
US$ 1800
For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/global-osteoporosis-market-patients-companies-and-forecast-483p.php
Š Renub Research
Page 14 of 16
to
Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India
Contact Information First Name:
Last Name:
Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:
© Renub Research
Page 15 of 16
3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor C-86, Sector -10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780
For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch
Š Renub Research
Page 16 of 16